Medpace Holdings, Inc. (MEDP) Financial Statements (2024 and earlier)

Company Profile

Business Address 5375 MEDPACE WAY
CINCINNATI, OH 45227
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments95,20739,13846,92228,26531,00742,551
Cash and cash equivalents95,20739,13846,92228,26531,00742,551
Receivables292,773275,058257,746253,404249,086225,695
Other undisclosed current assets60,90164,73162,95452,29357,64860,641
Total current assets:448,881378,927367,622333,962337,741328,887
Noncurrent Assets
Operating lease, right-of-use asset144,147139,863143,309139,068139,071135,389
Property, plant and equipment114,764114,817113,755109,849104,719103,538
Intangible assets, net (including goodwill)698,755699,304699,854700,404701,242702,080
Goodwill662,396662,396662,396662,396662,396662,396
Intangible assets, net (excluding goodwill)36,35936,90837,45838,00838,84639,684
Deferred income tax assets59,34351,76649,15748,08327,02326,441
Other noncurrent assets20,83122,26122,02621,12918,62919,118
Total noncurrent assets:1,037,8401,028,0111,028,1011,018,533990,684986,566
TOTAL ASSETS:1,486,7211,406,9381,395,7231,352,4951,328,4251,315,453
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities293,808265,533238,311243,194295,879201,992
Employee-related liabilities63,517
Accounts payable29,02333,60837,11033,06928,24528,800
Accrued liabilities264,785231,925201,201210,125204,117173,192
Deferred revenue518,755490,557466,040462,729417,927401,368
Debt  55,000115,00050,000139,700249,700
Other liabilities35,95541,34762,53847,54730,87925,899
Other undisclosed current liabilities     (63,517) 
Total current liabilities:848,518852,437881,889803,470820,868878,959
Noncurrent Liabilities
Long-term debt and lease obligation:     139,203134,977
Liabilities, other than long-term debt167,291163,441166,572162,63818,46918,265
Deferred income tax liabilities1,1281,0981,0901,0709111,002
Other liabilities23,12422,95322,79322,70117,55817,263
Operating lease, liability143,039139,390142,689138,867139,203134,977
Total noncurrent liabilities:167,291163,441166,572162,638157,672153,242
Total liabilities:1,015,8091,015,8781,048,461966,108978,5401,032,201
Equity
Equity, attributable to parent470,912391,060347,262386,387349,885283,252
Common stock307306306309309309
Treasury stock, value(12,322)(12,322)(12,322)(12,497)(14,243)(14,243)
Additional paid in capital795,994785,292778,691770,794759,986753,300
Accumulated other comprehensive loss(12,870)(11,194)(11,314)(12,392)(16,052)(9,972)
Accumulated deficit(300,197)(371,022)(408,099)(359,827)(380,115)(446,142)
Total equity:470,912391,060347,262386,387349,885283,252
TOTAL LIABILITIES AND EQUITY:1,486,7211,406,9381,395,7231,352,4951,328,4251,315,453

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues492,499460,868434,074394,098383,744351,207
Cost of revenue(365,635)(342,521)(309,293)(283,428)(269,661)(256,918)
Cost of goods and services sold(359,306)(336,551)(303,885)(278,367)(264,710)(252,211)
Gross profit:126,864118,347124,781110,670114,08394,289
Operating expenses(41,956)(39,954)(38,577)(34,239)(36,256)(34,053)
Operating income:84,90878,39386,20476,43177,82760,236
Nonoperating income (expense)(1,707)(2,649)(174)(2,786)4,0651,763
Other nonoperating income (expense)(1,602)(1,283)687(1,959)5,6492,311
Income from continuing operations before income taxes:83,20175,74486,03073,64581,89261,999
Income tax expense(12,651)(14,676)(13,136)(4,975)(15,865)(12,639)
Income from continuing operations:70,55061,06872,89468,67066,02749,360
Income before gain (loss) on sale of properties:66,02749,360
Net income attributable to parent:70,55061,06872,89468,67066,02749,360
Other undisclosed net loss available to common stockholders, basic(48)(41)(49)(45)(44)(31)
Net income available to common stockholders, diluted:70,50261,02772,84568,62565,98349,329

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income:70,55061,06872,89468,67066,02749,360
Comprehensive income:70,55061,06872,89468,67066,02749,360
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,676)1201,0783,660(6,080)(3,584)
Comprehensive income, net of tax, attributable to parent:68,87461,18873,97272,33059,94745,776

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: